Table 2 —

Prevalence of the metabolic syndrome and the different components of the metabolic syndrome* in male and female subjects of different age decades with NGT, abnormal IFG/IGT, and diabetic glucose tolerance

NGT
IFG/IGT
Type 2 diabetes
MaleFemaleMaleFemaleMaleFemale
Metablic syndrome 
 all 35–70 years 15 10 64 42 84 78 
 40–49 years 12 59 38 87 78 
 50–59 years 20 67 44 83 74 
 60–69 years 20 19 66 52 84 81 
Obesity 
 all 35–70 years 76 36 86 51 92 78 
 40–49 years 76 34 87 49 95 80 
 50–59 years 81 32 86 56 93 79 
 60–69 years 80 44 89 53 92 78 
Dyslipidemia 
 all 35–70 years 29 16 45 31 54 56 
 40–49 years 31 13 51 25 66 64 
 50–59 years 28 17 46 31 55 51 
 60–69 years 23 21 39 37 50§ 57 
Hypertension 
 all 35–70 years 23 24 31 35 55 59 
 40–49 years 20 17 19 31 42 47 
 50–59 years 27 29 41 34 55 53 
 60–69 years 35 41 39§ 47 59§ 67 
Microalbuminuria 
 all 35–70 years 22 12 
 40–49 years 14 18 
 50–59 years 19 12 
 60–69 years 9 26 11 
Insulin resistance 
 all 35–70 years 25 25 58 59 87 89 
 40–49 years 23 19 53 52 87 89 
 50–59 years 28 24 65 57 87 89 
 60–69 years 29 35 59 68 86 90 
NGT
IFG/IGT
Type 2 diabetes
MaleFemaleMaleFemaleMaleFemale
Metablic syndrome 
 all 35–70 years 15 10 64 42 84 78 
 40–49 years 12 59 38 87 78 
 50–59 years 20 67 44 83 74 
 60–69 years 20 19 66 52 84 81 
Obesity 
 all 35–70 years 76 36 86 51 92 78 
 40–49 years 76 34 87 49 95 80 
 50–59 years 81 32 86 56 93 79 
 60–69 years 80 44 89 53 92 78 
Dyslipidemia 
 all 35–70 years 29 16 45 31 54 56 
 40–49 years 31 13 51 25 66 64 
 50–59 years 28 17 46 31 55 51 
 60–69 years 23 21 39 37 50§ 57 
Hypertension 
 all 35–70 years 23 24 31 35 55 59 
 40–49 years 20 17 19 31 42 47 
 50–59 years 27 29 41 34 55 53 
 60–69 years 35 41 39§ 47 59§ 67 
Microalbuminuria 
 all 35–70 years 22 12 
 40–49 years 14 18 
 50–59 years 19 12 
 60–69 years 9 26 11 
Insulin resistance 
 all 35–70 years 25 25 58 59 87 89 
 40–49 years 23 19 53 52 87 89 
 50–59 years 28 24 65 57 87 89 
 60–69 years 29 35 59 68 86 90 

Data are %.

*

The definition of the metabolic syndrome was based on the recent WHO proposal (17);

P < 0.001 for differences in all variables between subjects with diabetes and NGT/IFG/IGT when men and women aged 35–70 years were compared separately;

P < 0.05;

§

P < 0.01;

P < 0.001 when age decade 60–69 was compared to age decade 40–49;

highest quartile of HOMAIR.

Close Modal

or Create an Account

Close Modal
Close Modal